Botulinum toxin-associated prolonged remission of idiopathic cervical dystonia.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Enhancing neurosurgical education: Lessons from the COVID-19 pandemic.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
IRON CHELATION in MOVEMENT DISORDERS: LOGICAL or IRONICAL.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Richter's syndrome of the central nervous system.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Imaging of sequential stroke-like episodes in adult MELAS.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Monoclonal Gammopathies of "Neurological Significance": Paraproteinemic Neuropathies.
...Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Genetic and epidemiological study of adult ataxia and spastic paraplegia in eastern Quebec.
...Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Recurrent laryngeal nerve palsy due to pseudotumor of left common carotid artery.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
A Focused Update on Tardive Dyskinesia.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Tardive dyskinesia (TD) is a delayed and potentially irreversible motor complication following chronic exposure to centrally acting dopamine receptor antagonists, mainly of the class of antipsychotics drugs. New generations of antipsychotic drugs reduced its mean prevalence to 20%, but it continues to mar the drug experience and social integration ...
Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin.
Published in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Dysgeusia is a frequent, yet underreported side effect of chemotherapy for cancer. We report here the first use of gabapentin in two glioblastoma patients who developed dysgeusia following intra-arterial administration of carboplatin or oral administration of lomustine, respectively. Treatment initiation was followed by resolution of taste alterati...
